PONOI CAPITAL, LP's Net Worth
$0
Estimate Recalculated Nov 11, 2024 08:40AM EST
Who is PONOI CAPITAL, LP?
PONOI CAPITAL, LP does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include IMMUNE DESIGN CORP., NGM BIOPHARMACEUTICALS INC, CONSTELLATION PHARMACEUTICALS INC, Revolution Medicines, Inc., RAPT Therapeutics, Inc., Nurix Therapeutics, Inc., and Arcus Biosciences, Inc..
SEC CIK
PONOI CAPITAL, LP's CIK is 0001707230
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
IMMUNE DESIGN CORP. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -6.64M |
$5.85 | -$38,861,210.70 |
0
|
Apr 2
| |||
Form 4
| +67.67% | 2.68M |
$4.10 | $10,992,100.00 | 6.64M |
Oct 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CONSTELLATION PHARMACEUTICALS INC No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -9.16% | -10.00K |
$36.95 | -$369,503.00 | 99.16K |
Feb 17
| |||
Form 4
| +1.18% | 30.11K |
$1.55 | $46,665.85 | 2.58M |
Dec 14
| |||
Form 4
| +0.69% | 41.67K |
$22.48 | $936,929.15 | 6.05M |
Mar 19 - Mar 20
| |||
Form 4
| +29.68% | 1.41M |
$8.50 | $11,999,994.00 | 6.17M |
Oct 3
| |||
Form 4
| +42,946.73% | 4.75M |
—
|
—
| 4.76M |
Jul 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Revolution Medicines, Inc. (RVMD) Snapshot price: $41.84
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -30.68% | -2.03M |
$36.40 | -$73,788,478.40 | 4.58M |
Nov 16
| |||
Form 4
|
∞
| 7.23K |
—
|
—
| 7.23K |
Feb 12 - Jun 17
| |||
Form 4
|
∞
| 7.98M |
—
|
—
| 7.98M |
Feb 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Nurix Therapeutics, Inc. (NRIX) Snapshot price: $23.33
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -43.68% | -2.68M |
—
|
—
| 3.45M |
May 5
| |||
Form 4
| +8,007.09% | 6.67M |
—
|
—
| 6.76M |
Jul 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Arcus Biosciences, Inc. (RCUS) Snapshot price: $15.72
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 3.54M |
—
|
—
| 3.54M |
Mar 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||